Systemic lupus erythematosus. ICD-10: M32.9. Musculoskeletal and chronic pain — common in desk, manual, and travel-heavy roles.
ICD-10 classification1
Hover highlighted terms for claim context · ? for more info
Document how symptoms limit material duties — attendance, stamina, cognition, safety, and reliability.
Claim note: Insurers test occupational incapacity — document how it blocks material duties , not the diagnosis label↗ alone.
Musculoskeletal and chronic pain — common in desk, manual, and travel-heavy roles.
Hover for a plain-language explanation · + adds to your health story.
Treating and assessing roles commonly involved with this condition on SA income-protection claims — click a role to see what they do.†
Generic active ingredients, registered brand formulations, SA strengths, and typical dosing — cross-linked to medication pages.†
Calcium-channel modulator for neuropathic pain and generalised anxiety — sedation and dizziness common.
Brands: Lyrica (pregabalin), Pregabalin (generic)
SA strengths: 25 mg capsule · 75 mg capsule · 150 mg capsule · 300 mg capsule
Typical SA dosing: Often titrated 75 mg BD to 150–300 mg BD for pain/anxiety per tolerability.
Anticonvulsant used for neuropathic pain — requires renal dose adjustment.
Brands: Neurontin (gabapentin), Gabapentin (generic)
SA strengths: 100 mg capsule · 300 mg capsule · 400 mg capsule
Typical SA dosing: Titrated in divided doses; typical maintenance varies widely by indication.
Weak opioid analgesic — seizure risk with SSRIs/SNRIs; sedation affects safety-critical work.
Brands: Tramadol, Tramal (tramadol)
SA strengths: 50 mg capsule · 100 mg SR tablet
Typical SA dosing: Often 50–100 mg qid PRN or SR 100–200 mg BD — max daily dose per insert.
Opioid analgesic — often combined with paracetamol; dependence and constipation risk.
Brands: Codeine phosphate
SA strengths: 30 mg tablet · 60 mg tablet
Typical SA dosing: Combo products: limit tablets per 24 h per package insert (e.g. Stilpane, Myprodol).
Non-opioid analgesic/antipyretic — hepatotoxicity risk above maximum daily dose.
Brands: Panado (paracetamol)
SA strengths: 500 mg tablet · 1 g tablet
Typical SA dosing: 500 mg–1 g qid PRN; do not exceed 4 g/day in adults without clinician direction.
NSAID anti-inflammatory — GI and renal precautions with chronic use.
Brands: Brufen (ibuprofen)
SA strengths: 200 mg tablet · 400 mg tablet · 600 mg tablet
Typical SA dosing: 200–400 mg TDS with food for musculoskeletal pain.
NSAID — enteric-coated tablets common in SA; cardiovascular/GI risk with long-term use.
Brands: Voltaren (diclofenac)
SA strengths: 25 mg tablet · 50 mg tablet · 50 mg enteric-coated tablet
Typical SA dosing: 25–50 mg BD–TDS per formulation and indication.
Anti-inflammatory pain relief — stomach and kidney precautions with long use.
Brands: Celebrex (celecoxib)
SA strengths: 100 mg capsule · 200 mg capsule
Typical SA dosing: Dose per treating clinician script and package insert.
Anti-inflammatory pain relief — stomach and kidney precautions with long use.
Brands: Arcoxia (etoricoxib)
SA strengths: 60 mg tablet · 90 mg tablet · 120 mg tablet
Typical SA dosing: Dose per treating clinician script and package insert.
Session-based referrals — not medicines. Separate from linked medications above; still evidence for functional capacity and recovery. Therapy directory → · Not scheduled →†
Prescribed rehabilitation for pain, injury, and mobility restoration.
Session formats: 30 min session · 45 min session · 60 min session
Typical plan: Usually 30–60 min sessions weekly to thrice weekly per referral.
Functional rehabilitation — workplace pacing, ergonomics, ADL retraining.
Session formats: 45 min session · 60 min session
Typical plan: 45–60 min sessions per treating plan.
Typical precipitants seen in SA income-protection claims — hover labels for context; use ? for claim tips. †
Own-occupation claims need duty-impact lines: which physical tasks became impossible and when.
Lifting, prolonged sitting, repetitive strain, or poor ergonomics — tie onset to specific work tasks.
Source: ClaimBuddy curatedMateriality matters: show a change in functional capacity after a definable event, not only chronic imaging findings.
Age-related disc or joint wear — insurers may argue gradual process; contrast stable baseline with post-inception worsening.
Source: ClaimBuddy curatedDate trap risk when HR sick leave and insurer disability tests use different anchors.
Returning too early, light-duty drift, or inconsistent rehab — affects waiting-period continuity evidence.
Source: ClaimBuddy curatedInsurers still require proof that post-inception change meets the policy disability test.
Genetic, environmental, and work factors often combine — build a chronology rather than a single cause label.
Source: ClaimBuddy curatedConditions that often overlap and amplify functional limits — pair with specialist reports and your functional matrix. †
Specialist reports should address both pain severity and duty endurance.
Chronic pain and mood disorders amplify disability — bidirectional relationship in evidence.
Source: ClaimBuddy curatedMateriality: show occupational impact change, not moral judgment on weight.
Weight load worsens joint pain — insurers may raise lifestyle arguments; focus on functional change.
Source: ClaimBuddy curatedClinical Atlas linked conditions and medication pages help map the full picture.
Check for mood, sleep, pain, or metabolic comorbidity that amplifies functional limits.
Source: ClaimBuddy curatedGuideline themes and evidence sources to pair with your treating plan — for claims context, not prescribing advice.†
Active rehabilitation, graded activity, and workplace pacing — prefer function over passive modalities alone.
Exercise, CBT, sleep hygiene, and pharmacotherapy combined; single-modality treatment rarely satisfies assessors.
ADL and workplace pacing assessments; pairs with material-duty mapping in functional capacity evidence.
Assessor is not your treating doctor — prepare material duties, chronology, and treating specialist reports separately.
ClaimBuddy collates SA-market brand names and strengths for intake — always verify against your script and clinician.
Sentrix Digital, Melbourne · ABN 29 203 554 753. Not medical, legal, or financial advice. Organisation and drafting only. Verify with treating practitioners, the PDS, and the trustee/insurer. Australian complaints: insurer/trustee IDR, then AFCA. · info@sentrixdigital.com · +61 (03) 9088 1341 · Admin login